A Phase 1b Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma
Phase of Trial: Phase I
Latest Information Update: 06 May 2016
At a glance
- Drugs Idelalisib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin; Paclitaxel
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 07 Jun 2017 Biomarkers information updated
- 03 May 2016 Status changed from recruiting to discontinued.
- 22 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.